Hikma Pharmaceuticals Market Cap

Hikma Pharmaceuticals has a market cap or net worth of $5.83 billion as of May 1, 2025. Its market cap has increased by 19.05% in one year.

Market Cap

5.83B

Enterprise Value

7.01B

Revenue

3.13B

Ranking

n/a

PE Ratio

16.25

Stock Price

$26.20

Market Cap Chart

Since November 2, 2005, Hikma Pharmaceuticals's market cap has increased from 833.84M to 5.83B, an increase of 599.65%. That is a compound annual growth rate of 10.49%.

Market Cap History

Date	Market Cap	% Change
Apr 29, 2025	5.79B	4.72%
Dec 31, 2024	5.53B	9.82%
Dec 29, 2023	5.04B	22.33%
Dec 30, 2022	4.12B	-40.78%
Dec 31, 2021	6.95B	-12.23%
Dec 31, 2020	7.92B	24.01%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.63B
Nika Pharmaceuticals	1.02B
Veradigm	743.17M
Glass House Brands	483.81M
Elite Pharmaceuticals	443.14M
Northwest Biotherapeutics	402.45M
CytoDyn	288.39M
BioStem Technologies	244.71M

Market Cap Rankings